These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 32513031

  • 1. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
    Kondo Y, Komaba H, Fukagawa M.
    Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
    [Abstract] [Full Text] [Related]

  • 2. Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients.
    Yamamoto S, Koyama D, Igarashi R, Maki T, Mizuno H, Furukawa Y, Kuro-O M.
    Intern Med; 2020 Jul; 59(3):345-355. PubMed ID: 32009088
    [Abstract] [Full Text] [Related]

  • 3. FGF23 and Phosphate-Cardiovascular Toxins in CKD.
    Vogt I, Haffner D, Leifheit-Nestler M.
    Toxins (Basel); 2019 Nov 06; 11(11):. PubMed ID: 31698866
    [Abstract] [Full Text] [Related]

  • 4. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H, Kuro-o M.
    Curr Opin Nephrol Hypertens; 2008 Jul 06; 17(4):368-72. PubMed ID: 18660672
    [Abstract] [Full Text] [Related]

  • 5. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M.
    Nephrol Dial Transplant; 2019 Jan 01; 34(1):15-21. PubMed ID: 29800324
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.
    Degirolamo C, Sabbà C, Moschetta A.
    Nat Rev Drug Discov; 2016 Jan 01; 15(1):51-69. PubMed ID: 26567701
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M, Komaba H, Fukagawa M.
    Contrib Nephrol; 2013 Jan 01; 180():110-23. PubMed ID: 23652554
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M, Santos-Araújo C, Poínhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M.
    Clin Nephrol; 2016 Mar 01; 85(3):135-41. PubMed ID: 26833300
    [Abstract] [Full Text] [Related]

  • 11. FGF23 and Klotho in chronic kidney disease.
    Olauson H, Larsson TE.
    Curr Opin Nephrol Hypertens; 2013 Jul 01; 22(4):397-404. PubMed ID: 23666415
    [Abstract] [Full Text] [Related]

  • 12. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.
    Marchelek-Mysliwiec M, Dziedziejko V, Dolegowka K, Pawlik A, Safranow K, Stepniewska J, Wisniewska M, Malyszko J, Ciechanowski K.
    J Appl Biomed; 2020 Aug 01; 18(2-3):61-69. PubMed ID: 34907727
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K, Nagano N, Tsuchiya K.
    Nephron Clin Pract; 2014 Aug 01; 128(1-2):1-10. PubMed ID: 25402964
    [Abstract] [Full Text] [Related]

  • 15. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML, Olgaard K, Lewin E.
    Int J Mol Sci; 2020 Nov 20; 21(22):. PubMed ID: 33233840
    [Abstract] [Full Text] [Related]

  • 16. The role of fibroblast growth factor-23 in cardiorenal syndrome.
    Kovesdy CP, Quarles LD.
    Nephron Clin Pract; 2013 Nov 20; 123(3-4):194-201. PubMed ID: 23942553
    [Abstract] [Full Text] [Related]

  • 17. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
    Ramanjaneya M, Bensila M, Bettahi I, Jerobin J, Samra TA, Aye MM, Alkasem M, Siveen KS, Sathyapalan T, Skarulis M, Atkin SL, Abou-Samra AB.
    Front Endocrinol (Lausanne); 2020 Nov 20; 11():568500. PubMed ID: 33101202
    [Abstract] [Full Text] [Related]

  • 18. Endocrine fibroblast growth factors in domestic animals.
    Brinker EJ, Hardcastle MR, Dittmer KE, Graff EC.
    Domest Anim Endocrinol; 2024 Oct 20; 89():106872. PubMed ID: 39059301
    [Abstract] [Full Text] [Related]

  • 19. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS, Urena-Torres P.
    Nephrol Ther; 2020 Mar 20; 16(2):83-92. PubMed ID: 31843356
    [Abstract] [Full Text] [Related]

  • 20. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.
    PLoS One; 2016 Mar 20; 11(7):e0156860. PubMed ID: 27400031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.